Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

148
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
148
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.0K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical Activity Disparities between Native Hawaiian and Pacific Islanders and Other Racial-Ethnic Groups in the United States.

Research square·2026
Same author

Natural Environment, Neighborhood Contexts, and Intra-Urban Suicidal Behavior.

GeoHealth·2026
Same author

Colorimetric measurement of water activity based on Bouligand-structured cellulose nanocrystal film.

Food chemistry·2026
Same author

Hybridization-Driven Herbivorous Adaptation in Fish: Morphological, Digestive, Transcriptome, and Microbial Evidence from a Hybrid of <i>Megalobrama amblycephala</i> (♀) × <i>Culter mongolicus</i> (♂).

International journal of molecular sciences·2026
Same author

Imaging thick objects with deep-subangstrom resolution and deep-subpicometer precision.

Science advances·2026
Same author

TeLLAgent: a dual-agent framework for reliable scientific discovery with tool-enhanced LLMs.

Chemical science·2026
Same journal

Proteomic Profiling of Extracellular Vesicle-Enriched Plasma Using Mag-Net for Biomarker Discovery in Pancreatic Ductal Adenocarcinoma.

Journal of proteome research·2026
Same journal

Computationally Efficient Bayesian Estimation of Graphical Networks for Omics Data.

Journal of proteome research·2026
Same journal

Hierarchy of MS-Based Evidence.

Journal of proteome research·2026
Same journal

Proteomic Profiling of Exosomes from HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma: Selective Cargo Packaging.

Journal of proteome research·2026
Same journal

Proteomic Analysis Identifies ATE1-Dependent Arginylation Dysregulation across Meningioma Grades.

Journal of proteome research·2026
Same journal

Proteomic Impact of Peripheral Expression of Mutant Huntingtin in <i>C. elegans</i>.

Journal of proteome research·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.8K

Deep-Learning-Based Drug-Target Interaction Prediction.

Ming Wen1, Zhimin Zhang1, Shaoyu Niu1

  • 1College of Chemistry and Chemical Engineering, Central South University , Changsha 410083, PR China.

Journal of Proteome Research
|March 7, 2017
PubMed
Summary
This summary is machine-generated.

DeepDTIs, a novel deep learning framework, accurately predicts drug-target interactions (DTIs) for drug repositioning. This computational approach enhances efficiency and provides insights into drug side effects and potential interactions.

Keywords:
deep learningdeep-delief networkdrug−target interaction predictionfeature extractionsemisupervised learning

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Area of Science:

  • Computational Biology
  • Pharmacology
  • Bioinformatics

Background:

  • Drug repositioning requires efficient identification of drug-target interactions (DTIs).
  • In silico DTI prediction accelerates experimental drug discovery but relies heavily on feature descriptors.
  • Existing methods often require target protein classification, limiting their scope.

Purpose of the Study:

  • To develop a deep learning framework, DeepDTIs, for accurate prediction of DTIs.
  • To overcome the limitations of traditional DTI prediction methods by avoiding target classification.
  • To enable prediction of interactions for new drugs and targets.

Main Methods:

  • Developed DeepDTIs, a deep learning framework for DTI prediction.
  • Employed unsupervised pretraining to abstract representations from raw input descriptors.
  • Utilized known interaction pairs to build a classification model.

Main Results:

  • DeepDTIs achieved performance comparable to or exceeding state-of-the-art methods.
  • The framework accurately predicts novel DTIs without prior target classification.
  • Demonstrated the capability to predict interactions for new drugs and targets.

Conclusions:

  • DeepDTIs offers a robust and efficient computational approach for DTI prediction.
  • The framework facilitates drug repositioning and exploration of drug-related interactions.
  • DeepDTIs advances in silico drug discovery by providing accurate and versatile DTI predictions.